Esther Landesman-Bollag, Ph.D.
Affiliations: | 2002 | Boston University, Boston, MA, United States |
Area:
Molecular Biology, Genetics, OncologyGoogle:
"Esther Landesman-Bollag"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| David C. Seldin | grad student | 2002 | Boston University | |
| (Oncogenic role of protein kinase CK2.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhou Y, Lian H, Shen N, et al. (2020) The multifaceted role of protein kinase CK2 in high-risk acute lymphoblastic leukemia. Haematologica |
| Lian H, Li D, Zhou Y, et al. (2016) CK2 inhibitor CX-4945 destabilizes NOTCH1 and synergizes with JQ1 against human T-acute lymphoblastic leukemic cells. Haematologica |
| Stanford EA, Wang Z, Novikov O, et al. (2016) The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells. Bmc Biology. 14: 20 |
| Seldin DC, Landesman-Bollag E. (2013) The Oncogenic Potential of CK2 Protein Kinase Ck2. 292-304 |
| Romagnoli M, Belguise K, Yu Z, et al. (2012) Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by Blimp-1-dependent repression of BMP-5. Cancer Research. 72: 6268-78 |
| Landesman-Bollag E, Belkina A, Hovey B, et al. (2011) Developmental and growth defects in mice with combined deficiency of CK2 catalytic genes. Molecular and Cellular Biochemistry. 356: 227-31 |
| Seldin DC, Lou DY, Toselli P, et al. (2008) Gene targeting of CK2 catalytic subunits. Molecular and Cellular Biochemistry. 316: 141-7 |
| Lou DY, Dominguez I, Toselli P, et al. (2008) The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development. Molecular and Cellular Biology. 28: 131-9 |
| Eddy SF, Guo S, Demicco EG, et al. (2005) Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells. Cancer Research. 65: 11375-83 |
| Seldin DC, Landesman-Bollag E, Farago M, et al. (2005) CK2 as a positive regulator of Wnt signalling and tumourigenesis. Molecular and Cellular Biochemistry. 274: 63-7 |